🟢 Neumora Therapeutics is trading 16.81% up in pre-market — No clear company-specific catalyst identified

Neumora Therapeutics is trading 16.81% up now at $1.40 in pre-market, with no clearly reported company-specific catalyst identified.

• Searches found no clearly reported September 10, 2026 announcement, earnings release, regulatory update, or analyst action explaining the move.
• The latest official investor-relations listing shows an August 14 quarterly update and earlier July pipeline news, with no newer release identified.
• Broader markets are mixed; recheck after the open for delayed filings or low-liquidity trading activity.